Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Preliminary data from a study conducted at the University of Oxford suggests that AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine is effective against the P1 or Brazilian variant, reports Reuters.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
- The data indicate that the vaccine will not need modification to protect against the variant.
- The study did not disclose the vaccine’s exact efficacy against the variant, but full results should be possibly released by March.
- Early results from a small study showed that the AstraZeneca vaccine was less effective against the South African variant, similar to P1.
- Subsequently, South Africa paused the use of the vaccine in the country.
- Reuters also reported that a small-sample lab study showed that Sinovac Biotech’s COVID-19 vaccine failed to generate a sufficient immune response.
- According to a recent study, one dose of either Pfizer Inc (NYSE: PFE)/BioNtech SE (NASDAQ: BNTX) or Oxford-AstraZeneca’s COVID-19 vaccine is more than 80% effective in reducing infections and severe illness among those aged over 80.
- Price Action: AZN shares are trading 0.73% higher at $47.59 in market trading hours on the last check Friday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.